These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11163666)

  • 1. Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge.
    Mata M; Yao ZJ; Zubair A; Syres K; Paterson Y
    Vaccine; 2001 Jan; 19(11-12):1435-45. PubMed ID: 11163666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.
    Friedman RS; Frankel FR; Xu Z; Lieberman J
    J Virol; 2000 Nov; 74(21):9987-93. PubMed ID: 11024127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.
    Frankel FR; Hegde S; Lieberman J; Paterson Y
    J Immunol; 1995 Nov; 155(10):4775-82. PubMed ID: 7594479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag.
    Zhao X; Zhang M; Li Z; Frankel FR
    J Virol; 2006 Sep; 80(18):8880-90. PubMed ID: 16940500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts.
    Peters C; Paterson Y
    Vaccine; 2003 Mar; 21(11-12):1187-94. PubMed ID: 12559797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes.
    Rayevskaya MV; Frankel FR
    J Virol; 2001 Mar; 75(6):2786-91. PubMed ID: 11222702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens.
    Mata M; Paterson Y
    J Immunol; 1999 Aug; 163(3):1449-56. PubMed ID: 10415046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
    Peters C; Peng X; Douven D; Pan ZK; Paterson Y
    J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge.
    Li Z; Zhang M; Zhou C; Zhao X; Iijima N; Frankel FR
    J Immunol; 2008 Feb; 180(4):2504-13. PubMed ID: 18250460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Listeria monocytogenes as an AIDS vaccine.
    Lieberman J; Frankel FR
    Vaccine; 2002 May; 20(15):2007-10. PubMed ID: 11983264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus.
    Stevens R; Howard KE; Nordone S; Burkhard M; Dean GA
    J Virol; 2004 Aug; 78(15):8210-8. PubMed ID: 15254192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.
    Zhang H; Fayad R; Wang X; Quinn D; Qiao L
    J Virol; 2004 Oct; 78(19):10249-57. PubMed ID: 15367590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants.
    Nakaya Y; Zheng H; García-Sastre A
    Vaccine; 2003 May; 21(17-18):2097-106. PubMed ID: 12706700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model.
    San Román B; De Andrés X; Muñoz PM; Obregón P; Asensio AC; Garrido V; Mansilla C; Arribillaga L; Lasarte JJ; De Andrés D; Amorena B; Grilló MJ
    Vaccine; 2012 Mar; 30(15):2564-9. PubMed ID: 22326778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion.
    Kwak H; Mustafa W; Speirs K; Abdool AJ; Paterson Y; Isaacs SN
    Virology; 2004 May; 322(2):337-48. PubMed ID: 15110531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
    McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
    J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.
    Boyer JD; Robinson TM; Maciag PC; Peng X; Johnson RS; Pavlakis G; Lewis MG; Shen A; Siliciano R; Brown CR; Weiner DB; Paterson Y
    Virology; 2005 Mar; 333(1):88-101. PubMed ID: 15708595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.
    Qiu JT; Liu B; Tian C; Pavlakis GN; Yu XF
    J Virol; 2000 Jul; 74(13):5997-6005. PubMed ID: 10846081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.